In other types of models, Cxcr2−/− mice have been injected with lung cancer cells [52], breast cancer cells [53,54], pancreatic cancer cells [44], or renal cancer cells [55], and the authors have observed that deletion of Cxcr2 was reducing tumor growth. This evidence concerns the gene CXCR2 and familial pancreatic carcinoma.